Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
Recruiting · NCT07110584 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors | Advanced Tumors | Recruiting | Phase 1 / Phase 2 | 2026-03-05 | NCT07110584 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ModeX Therapeutics, An OPKO Health Company | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Calvary Mater Newcastle | Waratah | Australia | 49 |
| Hadassah University Hospital-Ein Kerem | Jerusalem | Israel | 1 |
| Liverpool Hospital | Liverpool | Australia | 66 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Rambam Health Care Campus | Haifa | Israel | 73 |
| Tel Aviv Sourasky Medical Center | Tel Aviv | Israel | 60 |